Alveolar Proteinosis in COVID-19: Clinical Case
Pulmonary alveolar proteinosis (PAP) is a rare, diffuse lung disease characterized by accumulation of lipoprotein in lung surfactant in the alveolar space and terminal bronchioles, leading to impaired gas exchange and arterial hypoxemia. We present the case of a 51-year-old woman who was admitted wi...
Saved in:
Main Authors: | Silvia Martin Bote, Maria Angeles Herrera Morueco, Beatriz Arias Arcos, Javier García Lopez, Maria Belen Lopez-Muñiz Ballesteros |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Case Reports in Pulmonology |
Online Access: | http://dx.doi.org/10.1155/2022/1842566 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pulmonary Alveolar Proteinosis
by: Sandeep M Patel, et al.
Published: (2012-01-01) -
Pulmonary alveolar proteinosis flare in the setting of COVID pneumonia
by: Kevin M. Chen, et al.
Published: (2024-11-01) -
Pulmonary Alveolar Proteinosis in Setting of Inhaled Toxin Exposure and Chronic Substance Abuse
by: Meirui Li, et al.
Published: (2018-01-01) -
Case Report: Innovative anesthetic approaches for whole lung lavage in an infant with pulmonary alveolar proteinosis
by: Jiaxiang Chen, et al.
Published: (2025-01-01) -
Autoimmune pulmonary alveolar proteinosis developed during treatment for systemic sclerosis: a case report
by: Tomoki Kozono, et al.
Published: (2025-01-01)